4.5 Editorial Material

Parkinson Disease and Autoimmune Disorders-What Can We Learn From Genome-wide Pleiotropy?

期刊

JAMA NEUROLOGY
卷 74, 期 7, 页码 769-770

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jamaneurol.2017.0843

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo-Controlled Trial of Rasagiline

David J. Arpin, Trina Mitchell, Derek B. Archer, Roxana G. Burciu, Winston T. Chu, Hanzhi Gao, Thomas Guttuso, Christopher W. Hess, Song Lai, Irene A. Malaty, Nikolaus R. McFarland, Ofer Pasternak, Catherine C. Price, Aparna Wagle Shukla, Samuel S. Wu, Michael S. Okun, David E. Vaillancourt

Summary: The study did not find evidence that 1mg/day of rasagiline has a disease-modifying effect in Parkinson's Disease over 1 year. The free-water accumulation in pSN increased significantly over 1 year, and baseline free-water levels were related to clinical motor progression.

MOVEMENT DISORDERS (2022)

Article Clinical Neurology

Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation

Emily J. Koller, Kristen R. Ibanez, Quan Vo, Karen N. McFarland, Elsa Gonzalez De la Cruz, Lillian Zobel, Tristan Williams, Guilian Xu, Daniel Ryu, Preya Patel, Benoit Giasson, Stefan Prokop, Paramita Chakrabarty

Summary: The study reveals that different tau mutations exhibit varying degrees of synergy with A beta depending on the presence of cerebral deposits.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2022)

Article Clinical Neurology

Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease

Andrea Quattrone, Maria G. Bianco, Angelo Antonini, David E. Vaillancourt, Klaus Seppi, Roberto Ceravolo, Antonio P. Strafella, Gioacchino Tedeschi, Alessandro Tessitore, Roberto Cilia, Maurizio Morelli, Salvatore Nigro, Basilio Vescio, Pier Paolo Arcuri, Rosa De Micco, Mario Cirillo, Luca Weis, Eleonora Fiorenzato, Roberta Biundo, Roxana G. Burciu, Florian Krismer, Nikolaus R. McFarland, Christoph Mueller, Elke R. Gizewski, Mirco Cosottini, Eleonora Del Prete, Sonia Mazzucchi, Aldo Quattrone

Summary: This study developed an automated Magnetic Resonance Parkinsonism Index 2.0 (MRPI 2.0) algorithm to differentiate progressive supranuclear palsy-parkinsonism (PSP-P) from Parkinson's disease (PD) and validated its diagnostic performance in two large independent cohorts. The automated MRPI 2.0 showed excellent performance in distinguishing PSP-P from PD and control subjects in both cohorts, suggesting its generalizability. The use of the automated MRPI 2.0 algorithm could standardize measures in patients with PSP-P across centers and have a positive impact on multicenter studies and clinical trials.

MOVEMENT DISORDERS (2022)

Article Neurosciences

Impact of APOE genotype on prion-type propagation of tauopathy

Tristan Williams, Alejandra Jolie Ruiz, Angelica Maria Ruiz, Quan Vo, Wangchen Tsering, Guilian Xu, Karen McFarland, Benoit Giasson, Patrick Sullivan, David R. Borchelt, Paramita Chakrabarty

Summary: APOE isoforms differentially regulate the burden of Alzheimer's disease-associated neuropathologies, especially phosphorylated tau pathology. Among them, the APOE3 genotype in mice is more prone to accumulate tau protein and exhibit microglial reactions, with a stronger response to K18-tau infection, which might be a contributing factor to the increased risk of Alzheimer's disease. Additionally, we did not observe neurofibrillary tau tangles induced by APOE homozygous mice in our study.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

MhcII Regulates Transmission of α-Synuclein-Seeded Pathology in Mice

Elsa Gonzalez De la Cruz, Quan Vo, Katie Moon, Karen N. McFarland, Mary Weinrich, Tristan Williams, Benoit Giasson, Paramita Chakrabarty

Summary: MHCII molecules play a key role in the cellular immune response to alpha-synuclein, and this immune response may affect the transmission of alpha-syn seeds from the periphery to the CNS. Deficiency in MhcII accelerates the appearance of alpha-syn pathology and shortens the lifespan in PFF-seeded M83 mice.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Letter Clinical Neurology

Recommendations for Virtual Administration of the PSP Rating Scale

Anne-Marie Wills, Lawrence I. Golbe, Anthony E. Lang, Tao Xie, Marian L. Dale, Alberto Espay, Maria Carmela Tartaglia, Susan H. Fox, Sotirios Andreas Parashos, Nikolaus R. McFarland, Ruth B. Schneider, Federico Rodriguez-Porcel, Steven A. Gunzler, Alexander Pantelyat

MOVEMENT DISORDERS (2022)

Article Neurosciences

WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson's Disease Monocytes

Rebecca L. Wallings, Laura P. Hughes, Hannah A. Staley, Zachary D. Simon, Nikolaus R. McFarland, Roy N. Alcalay, Alicia Garrido, Maria Jose Marti, Eduardo Tolosa Sarro, Nicolas Dzamko, Malu Gamez Tansey

Summary: Both LRRK2 and GCase are potential targets for Parkinson's disease treatment, and their involvement in lysosome-related pathways has been suggested. This study developed a standardized protocol called WHOPPA using flow cytometry assays to measure LRRK2 and GCase activities in immune cells. The results showed increased LRRK2 levels and activity, decreased GCase index, and increased cytokine release in PD patient samples. The study also demonstrated a positive correlation between LRRK2 levels and the expression of pRab10 and HLA-DR in classical monocytes. This protocol could be used as a reliable and reproducible biomarker assay in larger cohorts of PD patients.

FRONTIERS IN CELLULAR NEUROSCIENCE (2022)

Article Clinical Neurology

Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways

Kristen R. Ibanez, Karen N. McFarland, Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, Elsa Gonzalez De la Cruz, Shivani Shah, Quan Vo, Xue Wang, Zachary Quicksall, Daniel Ryu, Cory Funk, Nilufer Ertekin-Taner, Stefan Prokop, Todd E. Golde, Paramita Chakrabarty

Summary: This study investigates the impact of the loss of function of Abi3-Gngt2 gene on the neuropathological hallmarks of AD, amyloid beta plaques, and tau pathology. The research provides insights into the role of inflammatory gliosis in AD and highlights the unpredictability of targeting immune pathways in AD.

ALZHEIMERS RESEARCH & THERAPY (2022)

Correction Biochemistry & Molecular Biology

Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021)

Tien Dam, Adam L. Boxer, Lawrence I. Golbe, Gunter U. Hoglinger, Huw R. Morris, Irene Litvan, Anthony E. Lang, Jean-Christophe Corvol, Ikuko Aiba, Michael Grundman, Lili Yang, Beth Tidemann-Miller, Joseph Kupferman, Kristine Harper, Kubra Kamisoglu, Michael J. Wald, Danielle L. Graham, Liz Gedney, John O'Gorman, Samantha Budd Haeberlein, Ikuko Aiba, Angelo Antonini, Diana Apetauerova, Jean-Philippe Azulay, Ernest Balaguer Martinez, Jee Bang, Paolo Barone, Matthew Barrett, Danny Bega, Daniela Berg, Koldo Berganzo Corrales, Yvette Bordelon, Adam L. Boxer, Moritz Brandt, Norbert Brueggemann, Giovanni Castelnovo, Roberto Ceravolo, Rosalind Chuang, Sun Ju Chung, Alistair Church, Jean-Christophe Corvol, Paola Cudia, Marian Dale, Luc Defebvre, Sophie Drapier, Erika D. Driver-Dunckley, Georg Ebersbach, Karla M. Eggert, Aaron Ellenbogen, Alexandre Eusebio, Andrew H. Evans, Natalia Fedorova, Elizabeth Finger, Alexandra Foubert-Samier, Boyd Ghosh, Lawrence Golbe, Francisco Grandas Perez, Murray Grossman, Deborah Hall, Kyoko Hamada, Kazuko Hasegawa, Guenter Hoeglinger, Lawrence Honig, David Houghton, Xuemei Huang, Stuart Isaacson, SeongBeom Koh, Jaime Kulisevsky Bojarski, Anthony E. Lang, Peter Nigel Leigh, Irene Litvan, Juan Jose Lopez Lozano, Jose Luis Lopez-Sendon Moreno, Albert Christian Ludolph, Ma Rosario Luquin Piudo, Irene Martinez Torres, Nikolaus McFarland, Wassilios Meissner, Tiago Mestre, Pablo Mir Rivera, Eric Molho, Britt Mollenhauer, Huw R. Morris, Miho Murata, Tomokazu Obi, Fabienne Ory Magne, Padraig O'Suilleabhain, Rajesh Pahwa, Alexander Pantelyat, Nicola Pavese, Dmitry Pokhabov, Johannes Prudlo, Federico Rodriguez-Porcel, James Rowe, Joseph Savitt, Alfons Schnitzler, Joerg B. Schulz, Klaus Seppi, Binit Shah, Holly Shill, David Shprecher, Maria Stamelou, Malcolm Steiger, Yuji Takahashi, Hiroshi Takigawa, Carmela Tartaglia, Lars Toenges, Daniel Truong, Winona Tse, Paul Tuite, Dieter Volc, Anne-Marie A. Wills, Dirk Woitalla, Tao Xie, Tatsuhiko Yuasa, Sarah Elizabeth Zauber, Theresa Zesiewicz

NATURE MEDICINE (2022)

Article Medicine, Research & Experimental

Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial

Charity G. Patterson, Elizabeth Joslin, Alexandra B. Gil, Wendy Spigle, Todd Nemet, Lana Chahine, Cory L. Christiansen, Ed Melanson, Wendy M. Kohrt, Martina Mancini, Deborah Josbeno, Katherine Balfany, Garett Griffith, Mac Kenzie Dunlap, Guillaume Lamotte, Erin Suttman, Danielle Larson, Chantale Branson, Kathleen E. McKee, Li Goelz, Cynthia Poon, Barbara Tilley, Un Jung Kang, Malu Gamez Tansey, Nijee Luthra, Caroline M. Tanner, Jacob M. Haus, Giamila Fantuzzi, Nikolaus R. McFarland, Paulina Gonzalez-Latapi, Tatiana Foroud, Robert Motl, Michael A. Schwarzschild, Tanya Simuni, Kenneth Marek, Anna Naito, Codrin Lungu, Daniel M. Corcos

Summary: This article introduces a research study on the effects of high-intensity endurance exercise on the progression of Parkinson's disease. The study aims to explore whether high-intensity endurance training can slow down the progression of the disease, thus improving the quality of life for patients.

TRIALS (2022)

Article Neurosciences

Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson's disease and atypical parkinsonism

Bradley J. Wilkes, Emily R. Tobin, David J. Arpin, Wei-en Wang, Michael S. Okun, Michael S. Jaffee, Nikolaus R. McFarland, Daniel M. Corcos, David E. Vaillancourt

Summary: Objective measures of disease progression using the Purdue Pegboard Test (PPT) were conducted in patients with Parkinson's disease (PD), atypical Parkinsonism, and healthy controls. The decline in PPT performance in PD patients correlated with motor symptom progression, while no such decline was seen in controls. Neuroimaging measures from the basal ganglia were significant predictors of PPT performance in PD, and cortical, basal ganglia, and cerebellar regions were predictors for atypical Parkinsonism. Accelerometry in PD patients showed diminished acceleration range and irregular patterns, which correlated with PPT scores.

NPJ PARKINSONS DISEASE (2023)

Meeting Abstract Clinical Neurology

Enhancing Pandemic-Sensitive Recruitment Strategies for a Remote, Randomized Placebo-Controlled Trial for Fracture Prevention in Patients with Neurodegenerative Parkinsonisms (P1-1.Virtual)

Nijee Luthra, Ethan Brown, Samuel Goldman, Rafael Zuzuarregui, Trisha Hue, Christopher Schambach, Ian Bledsoe, Michael Schwarzschild, E. Ray Dorsey, Alberto Espay, Irene Litvan, Nikolaus McFarland, Kyle Mitchell, David Standaert, James Beck, Helen Rowbotham, Cheryl Meng, Jacque Perkins, Primi Ranola, Raymundo Picos, Dana Kriesel, Kenneth Lyles, Steve Cummings, Caroline Tanner

NEUROLOGY (2022)

Article Neuroimaging

Advanced diffusion imaging to track progression in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

Trina Mitchell, Bradley J. Wilkes, Derek B. Archer, Winston T. Chu, Stephen A. Coombes, Song Lai, Nikolaus R. McFarland, Michael S. Okun, Mieniecia L. Black, Ellen Herschel, Tanya Simuni, Cynthia Comella, Mitra Afshari, Tao Xie, Hong Li, Todd B. Parrish, Ajay S. Kurani, Daniel M. Corcos, David E. Vaillancourt

Summary: Advanced diffusion imaging techniques can detect longitudinal changes in atypical Parkinsonian syndromes. The study found that MSAp and PSP had more declines in descending sensorimotor tracts compared to PD. PSP also showed longitudinal impairments in multiple transcallosal tracts, while MSAp and PD did not. Additionally, there were longitudinal changes in gray matter regions that had previously shown impairments in MSAp and PSP.

NEUROIMAGE-CLINICAL (2022)

Meeting Abstract Hospitality, Leisure, Sport & Tourism

Longitudinal Decline in Purdue Pegboard Performance in Parkinson's Disease

Emily R. Tobin, Bradely J. Wilkes, David J. Arpin, Michael S. Okun, Michael S. Jaffee, Nikolaus R. McFarland, Daniel M. Corcos, David E. Vaillancourt

JOURNAL OF SPORT & EXERCISE PSYCHOLOGY (2022)

Review Clinical Neurology

Microglia in Alzheimer's Disease: a Key Player in the Transition Between Homeostasis and Pathogenesis

Karen N. McFarland, Paramita Chakrabarty

Summary: Immune activation is associated with the development of proteinopathy in the brains of Alzheimer's dementia patients. There is accumulating evidence that microglial activation is not simply a reactive process to the proteinopathy, but a dynamic evolving process that regulates brain organ health. While immune activation can be beneficial under certain circumstances, chronic activation leads to neurodegeneration. A deeper understanding of the relationship between microglial functional states and brain organ health may lead to new interventions and therapies for Alzheimer's disease.

NEUROTHERAPEUTICS (2022)

暂无数据